PMS / vigilance
Mastering Vigilance Reporting in Germany
Whitepaper · EU MDR 2017/745
PMS / vigilanceAllemagne / G-BAUSA / FDA

WHAT THIS PAGE COVERS
1
Mastering Vigilance Reporting in Germany
European CRO for medical devices, aligned with Regulation (EU) 2017/745.
Trusted by manufacturers
Leading medical device teams work with Eclevar


A guide to post-market vigilance requirements for MedTech professionals.
Serious incidentsFSCABfArMGermany
In this whitepaper you’ll find
Stay compliant and keep patients safe across the device lifecycle. Complete the form to download the guide.
- ›The vigilance reporting obligations for medical devices on the German market under EU MDR
- ›How to identify and report serious incidents and Field Safety Corrective Actions (FSCA), with timelines
- ›The role of the BfArM and the manufacturer’s responsibilities post-market
- ›Understand your vigilance obligations for devices placed on the German market
- ›Report serious incidents and FSCA correctly and within the required timelines
- ›Build a robust post-market vigilance process aligned with EU MDR and international standards

EUCROF Platinum Award 2026xShare Open Call for Clinical Research, co-funded by the European Union
Official content
Our content, signed Eclevar.
Whitepapers and publications produced by our teams with our notified body partners.
Keep reading
Related pages
The services and topics connected to this page.
Germany: How the G-BA, NUB and Paragraph 137h Decide WhetherSAE Reporting in Germany: A Guide for Clinical InvEU MDR & IVDR 2017/745: Medical Device Regulation Guide 2026Medical Device Reimbursement in Europe - Country-by-CountryFDA Audit Preparation Guide for Medical Device ManufacturersPre-CE Mark Clinical Investigation | Medical DeviceHuman Repeat Insult Patch Test & Skin Prick Test:US FDA & EU MDR Clinical CorridorHuman Repeat Insult Patch Test and Skin Prick TestECLEVAR MEDTECH and Micron Agreed to a Business Al
Start the conversation
Tell us where your evidence stands today
Send us the device, the claim and the deadline. You get a written answer within 24 hours.
Your documents are reviewed confidentially. An NDA can be signed before we receive any technical or clinical information.
